Yaz, Yasmin and Ocella®

Studies Prove that Women Taking Yaz, Yasmin Have an Increased Blood Clot Risk of 75 Percent
October 28, 2011

The U.S. Food and Drug Administration (FDA) and the BMJ, f/n/a British Medical Journal, recently released studies which prove that women taking Yaz, Yasmin have a 75 percent greater chance of experiencing a serious blood clot.  Sources:  BMJ Study, New York Times, and NewsInferno.

Indy woman speaks on birth control control suit
Wish-TV 8 article (Feb. 10, 2010)

Hoosier Women sue Bayer over Yasmin pill article (Feb. 8, 2010)

Indiana women sue birth control drugmaker
Fox59 article (Feb. 8, 2010)

Suit claims birth control warning not enough
WishTV 8 article (Feb. 8, 2010)

Yaz and Yasmin (drospirenone/ethinyl estradiol) are oral contraceptive combination drugs, containing a combination of the hormones estrogen (ethinyl estradiol) and progestin (drospirenone). The only difference between these two drugs is the amount of estrogen that they contain (Yasmin, 30 mcg; Yaz, 20 mcg). The generic equivalent of Yasmin is Ocella.  The drugs prevent ovulation and also cause changes in the lining of the uterus; it becomes harder for a sperm to reach the uterus and harder for an egg that is fertilized to attach to the uterus.

Yaz and Yasmin have three FDA-approved uses: Pregnancy prevention, alleviation of premenstrual dysphoric disorder (PMDD), and treatment of moderate acne in women who would want to use an oral contraceptive for birth control. Yaz and Yasmin are manufactured by Bayer HealthCare Pharmaceuticals, Inc.  Ocella is manufactured by Barr Laboratories.

In October of 2008, a warning letter was sent by the Food and Drug Administration to Bayer HealthCare Pharmaceuticals, Inc., in response to claims the company had made for Yaz, a very popular and heavily promoted birth control pill.  The warning letter alleged that Yaz has additional risks compared to other birth control pills because it contains drospirenone, a progestin hormone that can increase potassium levels.

Among the serious and debilitating injuries reported from drospirenone in birth control are:
  • heart attacks
  • blood clots
  • strokes
  • pulmonary embolisms
  • deep vein thrombosis
  • liver or kidney failure
  • gall bladder disease
  • pancreatitis, and other serious injuries
  • death
If you or a loved one have used Yaz, Yasmin or Ocella® and have suffered a heart attack, blood clot, stroke, death, or other serious disorder listed above, please contact one of our lawyers today, to assess any potential claim and possible lawsuit.